The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”
Recent Posts
- Other Barks and Bites for Friday, December 6: GAO Releases Third-Party Litigation Funding Report; PQA Must Identify Members in VLSI Patent Litigation; CAFC Issues Two Precedential Decisions
- Newman Makes Another Bid to Reverse Suspension from CAFC
- CAFC Delivers Win for Meta in Precedential Decision
- USPTO Officially Withdraws Terminal Disclaimer Proposal
- Judge Newman’s Suspension by the CAFC Has Marred Public Faith in the Federal Judiciary